These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 32231056)

  • 1. Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease.
    Schneider S; Campion NJ; Villazala-Merino S; Liu DT; Bartosik T; Landegger LD; Ahmadi N; Mueller CA; Vyskocil E; Stanek V; Quint T; Bangert C; Eckl-Dorna J
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32231056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in men and women suffering from CRSwNP and AERD in quality of life.
    Bartosik TJ; Liu DT; Campion NJ; Villazala-Merino S; Janik S; Dahm V; Mueller CA; Vyskocil E; Stanek V; Quint T; Bangert C; Eckl-Dorna J; Schneider S
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1419-1427. PubMed ID: 33063145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
    Armengot-Carceller M; Gómez-Gómez MJ; García-Navalón C; Doménech-Campos E; Muñoz-Fernández N; Miguel AG; Marco-Algarra J; Palop-Cervera M; Piñero AG
    Am J Rhinol Allergy; 2021 Jul; 35(4):516-524. PubMed ID: 33153272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype.
    Miglani A; Divekar RD; Azar A; Rank MA; Lal D
    Int Forum Allergy Rhinol; 2018 Sep; 8(9):1047-1051. PubMed ID: 29851243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.
    Buchheit KM; Dwyer DF; Ordovas-Montanes J; Katz HR; Lewis E; Vukovic M; Lai J; Bankova LG; Bhattacharyya N; Shalek AK; Barrett NA; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2020 Jun; 145(6):1574-1584. PubMed ID: 32199912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.
    Takahashi T; Kato A; Berdnikovs S; Stevens WW; Suh LA; Norton JE; Carter RG; Harris KE; Peters AT; Hulse KE; Grammer LC; Welch KC; Shintani-Smith S; Tan BK; Conley DB; Kern RC; Bochner BS; Schleimer RP
    J Allergy Clin Immunol; 2017 Sep; 140(3):720-729. PubMed ID: 28238741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Rhinosinusitis Patients With and Without Polyps Experience Different Symptom Perception and Quality of Life Burdens.
    Talat R; Speth MM; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Am J Rhinol Allergy; 2020 Nov; 34(6):742-750. PubMed ID: 32437223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of air pollutants, airborne occupational exposures, and chronic rhinosinusitis disease severity.
    Velasquez N; Moore JA; Boudreau RM; Mady LJ; Lee SE
    Int Forum Allergy Rhinol; 2020 Feb; 10(2):175-182. PubMed ID: 31661614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune endotyping and gene expression profile of patients with chronic rhinosinusitis with nasal polyps in the aspirin-exacerbated respiratory disease (AERD) and the non-AERD subgroups.
    Nazari J; Shahba F; Jafariaghdam N; Mohebbi S; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Atashrazm F; Amini S; Roomiani M; Jamee M; Babaheidarian P; Khoshmirsafa M; Nabavi M
    Allergy Asthma Clin Immunol; 2024 Feb; 20(1):14. PubMed ID: 38360807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Rhinosinusitis Outcomes of Patients With Aspirin-Exacerbated Respiratory Disease Treated With Budesonide Irrigations: A Case Series.
    Talat R; Gengler I; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Ann Otol Rhinol Laryngol; 2022 Oct; 131(10):1130-1136. PubMed ID: 34775833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
    Sohail A; Hacker J; Ryan T; McGill A; Bergmark R; Bhattacharyya N; Lee SE; Maxfield A; Roditi R; Julé AM; Griffith A; Lederer J; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol; 2024 Feb; 153(2):527-532. PubMed ID: 37898408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
    Stevens WW; Ocampo CJ; Berdnikovs S; Sakashita M; Mahdavinia M; Suh L; Takabayashi T; Norton JE; Hulse KE; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Kato A; Harris KE; Carter RG; Fujieda S; Kern RC; Schleimer RP
    Am J Respir Crit Care Med; 2015 Sep; 192(6):682-94. PubMed ID: 26067893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis.
    Thompson CF; Price CP; Huang JH; Min JY; Suh LA; Shintani-Smith S; Conley DB; Schleimer RP; Kern RC; Tan BK
    Int Forum Allergy Rhinol; 2016 May; 6(5):500-7. PubMed ID: 26683389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps.
    Domínguez-Sosa MS; Cabrera-Ramírez MS; Marrero-Ramos MDC; Dávila-Quintana D; Cabrera-López C; Carrillo-Díaz T; Del Rosario JJB
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.
    Nordström A; Jangard M; Svedberg M; Ryott M; Kumlin M
    Prostaglandins Leukot Essent Fatty Acids; 2022 Sep; 184():102474. PubMed ID: 35917595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of higher symptomatic airway load in patients with chronic rhinosinusitis.
    Eskeland Ø; Danielsen KA; Dahl F; Fridrich K; Orszagh VC; Bachmann-Harildstad G; Burum-Auensen E
    BMC Ear Nose Throat Disord; 2017; 17():15. PubMed ID: 29299022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and eosinophilia in the nasal mucosa of patients with different clinical phenotypes of chronic rhinosinusitis.
    Vukadinović T; Vuksanović Božarić A; Vukomanović Đurđević B; Radunović M; Perić A
    J Infect Dev Ctries; 2023 Oct; 17(10):1480-1488. PubMed ID: 37956383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis.
    Morrissey DK; Bassiouni A; Psaltis AJ; Naidoo Y; Wormald PJ
    Int Forum Allergy Rhinol; 2016 Aug; 6(8):820-5. PubMed ID: 26992029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of sino-nasal outcome test and nasal polyp score in dupilumab-treated chronic rhinosinusitis with nasal polyps.
    Mauthe T; Ryser FS; Brühlmann C; Yalamanoglu A; Meerwein C; Steiner UC; Soyka MB
    Eur Arch Otorhinolaryngol; 2024 Sep; ():. PubMed ID: 39306591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.